Literature DB >> 3979425

Lorazepam and pentobarbital discrimination: interactions with CGS 8216 and caffeine.

N A Ator, R R Griffiths.   

Abstract

Baboons and rats were trained under a two-lever, food-reinforced drug discrimination procedure. The training drug was either lorazepam (1.0 mg/kg) or pentobarbital (5.6 mg/kg in baboons, 10.0 mg/kg in rats). Under test conditions, a range of training drug doses occasioned 100% drug lever responding. CGS 8216 (3.2-10.0 mg/kg) combined with lorazepam produced a complete shift to the no-drug lever in both species; this shift was surmountable with higher doses of lorazepam. CGS 8216 (32.0 mg/kg) combined with pentobarbital produced a statistically significant decrease in drug-lever responding in rats, and in baboons CGS 8216 initially, but not subsequently, produced a complete shift to the no-drug lever. Caffeine (0.32-10.0 mg/kg) combined with lorazepam inconsistently decreased drug-lever responding across multiple determinations in baboons and significantly decreased drug lever responding in rats. Caffeine combined with pentobarbital also yielded an inconsistent decrease in drug lever responding in baboons but there was no effect in rats. Thus the most reliable and complete antagonism across species was obtained with the CGS 8216/lorazepam combinations.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3979425     DOI: 10.1016/0014-2999(85)90056-1

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  11 in total

1.  Withdrawal from chronic nicotine substitutes partially for the interoceptive stimulus produced by pentylenetetrazol (PTZ).

Authors:  C M Harris; M W Emmett-Oglesby; N G Robinson; H Lal
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  Further investigation of the stimulus properties of chlordiazepoxide and zolpidem. Agonism and antagonism by two novel benzodiazepines.

Authors:  D J Sanger
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

3.  Trends in drug discrimination research analysed with a cross-indexed bibliography, 1984-1987.

Authors:  I P Stolerman; F Rasul; P J Shine
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

4.  Benzodiazepine-induced hyperphagia: stereospecificity and antagonism by pyrazoloquinolines, CGS 9895 and CGS 9896.

Authors:  S J Cooper; R E Yerbury
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

5.  Self-administration in baboons and the discriminative stimulus effects in rats of bupropion, nomifensine, diclofensine and imipramine.

Authors:  R J Lamb; R R Griffiths
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

6.  Differential generalization to pentobarbital in rats trained to discriminate lorazepam, chlordiazepoxide, diazepam, or triazolam.

Authors:  N A Ator; R R Griffiths
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

7.  Stimulus properties of benzodiazepines: correlations with binding affinities, therapeutic potency, and structure activity relationships (SAR).

Authors:  R Young; R A Glennon
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

8.  Discriminative stimulus properties of the benzodiazepine receptor antagonist flumazenil.

Authors:  G A Rowan; I Lucki
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

9.  The discriminative stimulus properties of zolpidem, a novel imidazopyridine hypnotic.

Authors:  D J Sanger; B Zivkovic
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

10.  Discriminative stimulus properties of the benzodiazepine receptor inverse agonist methyl-6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate (DMCM).

Authors:  L G Kirby; G A Rowan; R L Smith; I Lucki
Journal:  Psychopharmacology (Berl)       Date:  1994-01       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.